跳至主要内容
临床试验/NCT03648151
NCT03648151已完成不适用

Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients

The First Affiliated Hospital of Shanxi Medical University2 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2010年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000
试验地点
2
主要终点
Overall survival (OS) of lung cancer patients

研究概览

简要总结

Radiomics is an attractive field in objectively quantifying image features, and may overcome the subjectivity of visually interpreting computed tomography (CT), or positron emission tomography (PET). It is reported that the features related to treatment response, outcomes, tumor staging, tissue identification, and cancer genetics. Therefore, the investigators try to explore the key features for the outcome of lung cancer patients.

详细描述

Radiomic Features:

PET/CT images, including other kinds of CT serials, were transported into a personal computer. Using the open source software of 3D-Slicer, volumes of interest (VOIs) for primary tumor, or even lymph nodes, was semi-automatically or manually segmented. And then, radiomic features were extracted.

PET Parameters:

Using combined CT VOIs, corresponding PET standard uptake value (SUV, no unit) were measured. For a foci (either tumor, or lymph node), mean, sum and maximum SUV were documented, and were used for training and validating models alongside radiomic features.

Feature Selection:

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Pathologically diagnosed as lung caner.
  • •Accepted PET/CT scans at the hospitals either affiliated to Shanxi Medical University or Anhui Medical University
  • •Both PET and CT serials can be obtained
  • •Can be followed for treatment modalities (including chemotherapy regimens, radiotherapy dose, and et al), survival time and status, and other related information.

排除标准

  • •Simultaneously suffering from the cancers from other tissues and organs
  • •Have a history of diabetes, chronic heart diseases, or chronic renal failure

结局指标

主要结局

Overall survival (OS) of lung cancer patients

时间窗: The patients were followed to December 31, 2019

The time from the scan date to death for any reason

次要结局

未报告次要终点

研究者

发起方
The First Affiliated Hospital of Shanxi Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hongwei Si

Chief physician

The First Affiliated Hospital of Shanxi Medical University

研究点 (2)

Loading locations...

相似试验